Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 17.65 BATS BZX Real-Time Price As of 10:08am ET |  -0.05 / -0.28%Today’s Change | 9.88 Today|||52-Week Range 19.90 | +17.28% Year-to-Date |
| Previous close | 17.70 |
| Today’s open | 17.80 |
| Day’s range | 17.58 - 17.80 |
| Volume | 10,758 |
| Average volume (3 months) | 868,504 |
| Market cap | $1.3B |
| Dividend yield | -- |
| Earnings growth (last year) | +76.52% |
| Earnings growth (this year) | -365.97% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +22.27% |
| P/E ratio | NM |
| Price/Sales | 9.43 |
| Price/Book | 3.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| XLRNAcceleron Pharma Inc | +0.11 | +0.37% |
| FPRXFive Prime Therapeut... | +0.27 | +0.88% |
| EPZMEpizyme Inc | +0.20 | +1.40% |
| CHRSCoherus BioSciences ... | -0.20 | -1.30% |
| Next reporting date | August 3, 2017 |
| EPS forecast (this quarter) | -$0.49 |
| Annual revenue (last year) | $109.6M |
| Annual profit (last year) | -$21.0M |
| Net profit margin | -19.16% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Craig A. Wheeler |
Chief Financial Officer & Senior Vice President Scott M. Storer |
Corporate headquarters Cambridge, Massachusetts |
